Mitral stenosis prevention: Difference between revisions

Jump to navigation Jump to search
(Created page with "_NOTOC__ {{Mitral stenosis prevention}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the primary prevention of [disease name]. OR There are no availa...")
 
Line 1: Line 1:
_NOTOC__
{{Mitral stenosis prevention}}
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}  


==Overview==
==Overview==
There are no established measures for the primary prevention of [disease name].
Effective measures for the primary prevention of mitral stenosis include  preventing of endocarditisa and decreasing new patients of rheumatic fever.


OR
<br />
 
There are no available vaccines against [disease name].
 
OR
 
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
 
OR
 
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].


==Primary Prevention==
==Primary Prevention==

Revision as of 14:08, 10 April 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Effective measures for the primary prevention of mitral stenosis include preventing of endocarditisa and decreasing new patients of rheumatic fever.


Primary Prevention

There are no established measures for the primary prevention of [disease name].

OR

There are no available vaccines against [disease name].

OR

Effective measures for the primary prevention of [disease name] include:

  • [Measure1]
  • [Measure2]
  • [Measure3]

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:

  • [Strategy 1]
  • [Strategy 2]
  • [Strategy 3]

References

Template:WH Template:WS